ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00121628
Recruitment Status : Completed
First Posted : July 21, 2005
Last Update Posted : October 9, 2013
Sponsor:
Information provided by (Responsible Party):
Amgen